Extracorporeal Membrane Oxygenation (ECMO) Devices Market By Offerings (Integrated Systems, Components (Oxygenators, Catheter, Heat Exchangers, Pumps, Tubing Kits, Back-up Battery, Others), Integrated Sensors); By System Type (VA ECMO, VV ECMO); By Scope of Use (Intensive Care, Operation Theatres, Emergency Medicine, Cardiology, Cardiac Surgery, Others); By Diseases (Acute Respiratory Distress Syndrome (ARDS) Secondary to Pneumonia, Aspiration, Severe Air Leak, Refractory Septic / Cardiogenic Shock, Myocarditis - Viral, Scorpion Sting, Post Arrest Shock, Meconium Aspiration, Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension, Swine Flu infection (H1N1), COVID-19, Poisoning, Others); By Distribution Channel (Online, Offline); By End Users (Hospitals/Clinics, Research Centers, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Spain, Germany, Italy, Nordic Countries , Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia), Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
The respiratory and cardiovascular systems for humans are regarded as one of the key components in the body. The healthcare sector has been observed to be keen on the development and deployment of solutions for respiratory care owing to the importance of the system along with frequency of causes related to the system. Some of the notable disorders related to the respiratory system include lung cancer, pneumonia, respiratory tract infections and chronic obstructive pulmonary disease (COPD) among others. Numerous devices and assemblies are utilized by healthcare facilities in order to assess and treat these disorders across various regions. These disorders are observed to either affect specific areas in the respiratory system or hamper the overall operations of the system through impact across key components in the system. Conditions like these have alerted medical researchers to develop innovative strategies in order to mitigate risks to the respiratory system of their patients. According to the severity of the disorders on specific parts or on the overall system, medical professionals across various healthcare facilities create dedicated plans of action. Extracorporeal Membrane Oxygenation (ECMO) is observed to be a notable addition to the widespread portfolio of processes used in the care provided for patients suffering from severe respiratory disorders. Global Extracorporeal Membrane Oxygenation (ECMO) devices market was estimated to be US$ 308.10 million in 2019 and is expected to reach US$ 812.09 million by 2028, growing at a CAGR of 13.02% during the forecast period (2020-2028).
Extracorporeal Membrane Oxygenation (ECMO) devices are used in medical facilities in order to help patients with the process in providing the patient’s body with oxygen and remove carbon dioxide from the body. In this procedure, the devices also provide the body with optimal levels of blood for various processes. The oxygenation process allows normal respiratory functions to happen for the patient with lower stress on the lungs. This is vital in cases related to severe lung disorders where the lungs are seen to be operating in a limited capacity. The demand for market offerings is growing due to the importance of the devices in the care provision stage along with growing demand from various medical facilities. Countries from the region of North America are observed to be notable contributors for the respiratory care sector from the development and adoption phases. Increasing investments towards strengthening the infrastructure for preventing, assessing, and mitigating risks related to various systems in the body have led to a positive outlook for the market. Market participants have been observed to target users in the region for improving their customer base and market revenue. The region has been observed to hold manufacturing and distribution of market offerings and has been a notable factor in the growth of the market. In addition to this, the demand for developed market offerings has led to the prevalence of newer market participants in other regions along with dedicated investments for product development from traditional manufacturers in these regions. The region of Asia Pacific has been observed to be a major investment area for the market from the perspective of manufacturing and development. Furthermore, companies in Asia Pacific have also undertaken collaborative initiatives for various components in the oxygenation system in order to create optimized products and devices. These efforts from companies are expected to aid the growth of the market over the forecast period. The growth of end users on the global scale along with the approval for the usage of market offerings in helping patients suffering from the novel coronavirus has been helpful for propelling the demand for devices in the market. These factors are expected to be vital for the growth of the market.
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue & Forecast, (US$ Million), 2015 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research of Extracorporeal Membrane Oxygenation (ECMO) devices market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the Extracorporeal Membrane Oxygenation (ECMO) devices market are ALung Technologies, Inc., ORMED Medizintechnik GmbH & Co. KG, CytoSorbents Europe GmbH, EUROSETS, Fresenius Medical Care,Getinge AB, LivaNova PLC (CardiacAssist, Inc), MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corporation, NIPRO, and Terumo Cardiovascular Systems Corporation, among others.
Extracorporeal Membrane Oxygenation (ECMO) Devices Market:
By Offerings
- Integrated Systems
- Components
- Oxygenators
- Catheter
- Heat Exchangers
- Pumps
- Tubing Kits
- Back-up Battery
- Others
- Integrated Sensors
By System Type
- VA ECMO
- VV ECMO
By Scope of Use
- Intensive care
- Operation Theatres
- Emergency Medicine
- Cardiology
- Cardiac Surgery
- Others
By Diseases
- Acute Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe air leak
- Refractory Septic / Cardiogenic Shock
- Myocarditis - viral, scorpion sting
- Post Arrest shock
- Meconium Aspiration
- Congenital Diaphragmatic Hernia
- Persistent Pulmonary Hypertension
- Swine Flu infection (H1N1)
- COVID-19
- Poisoning
- Others
By Distribution Channel
- Online
- Offline
By End Users
- Hospitals/Clinics
- Research Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Extracorporeal Membrane Oxygenation (ECMO) Devices Market
6. Market
Synopsis: Extracorporeal Membrane
Oxygenation (ECMO) Devices Market
7. Extracorporeal
Membrane Oxygenation (ECMO) Devices Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Extracorporeal Membrane Oxygenation (ECMO) Devices Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Extracorporeal Membrane Oxygenation (ECMO)
Devices Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Extracorporeal Membrane Oxygenation (ECMO) Devices Market
8. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
8.2. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
8.2.1. Integrated
Systems
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2019
8.2.1.3. Market
Forecast, 2020 – 2028
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2019
8.2.1.5.1.2. Market
Forecast, 2020 – 2028
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2019
8.2.1.5.2.2. Market
Forecast, 2020 – 2028
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2019
8.2.1.5.3.2. Market
Forecast, 2020 – 2028
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2019
8.2.1.5.4.2. Market
Forecast, 2020 – 2028
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2019
8.2.1.5.5.2. Market
Forecast, 2020 – 2028
8.2.2. Components
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Oxygenators, Catheter, Heat
Exchangers, Pumps, Tubing Kits, Back-up Battery, Others)
8.2.2.1. Oxygenators
8.2.2.2. Catheter
8.2.2.3. Heat
Exchangers
8.2.2.4. Pumps
8.2.2.5. Tubing
Kits
8.2.2.6. Back-up
Battery
8.2.2.7. Others
8.2.3. Integrated
Sensors
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2019
8.2.3.3. Market
Forecast, 2020 – 2028
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2019
8.2.3.5.1.2. Market
Forecast, 2020 – 2028
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2019
8.2.3.5.2.2. Market
Forecast, 2020 – 2028
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2019
8.2.3.5.3.2. Market
Forecast, 2020 – 2028
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2019
8.2.3.5.4.2. Market
Forecast, 2020 – 2028
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2019
8.2.3.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
9.2.1. VA ECMO
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. VV ECMO
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By
System Type
10. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
10.1. Overview
10.2. Global Extracorporeal
Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and Forecasts, By
Scope of Use
10.2.1. Intensive
care
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Operation
Theatres
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Emergency
Medicine
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Cardiology
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.2.5. Cardiac
Surgery
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 – 2019
10.2.5.3. Market
Forecast, 2020 – 2028
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 – 2019
10.2.5.5.1.2. Market
Forecast, 2020 – 2028
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2019
10.2.5.5.2.2. Market
Forecast, 2020 – 2028
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2019
10.2.5.5.3.2. Market
Forecast, 2020 – 2028
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2019
10.2.5.5.4.2. Market
Forecast, 2020 – 2028
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 – 2019
10.2.5.5.5.2. Market
Forecast, 2020 – 2028
10.2.6. Others
10.2.6.1. Definition
10.2.6.2. Market
Estimation and Penetration, 2015 – 2019
10.2.6.3. Market
Forecast, 2020 – 2028
10.2.6.4. Compound
Annual Growth Rate (CAGR)
10.2.6.5. Regional
Bifurcation
10.2.6.5.1. North
America
10.2.6.5.1.1. Market
Estimation, 2015 – 2019
10.2.6.5.1.2. Market
Forecast, 2020 – 2028
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 – 2019
10.2.6.5.2.2. Market
Forecast, 2020 – 2028
10.2.6.5.3. Asia
Pacific
10.2.6.5.3.1. Market
Estimation, 2015 – 2019
10.2.6.5.3.2. Market
Forecast, 2020 – 2028
10.2.6.5.4. Middle
East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 – 2019
10.2.6.5.4.2. Market
Forecast, 2020 – 2028
10.2.6.5.5. Latin
America
10.2.6.5.5.1. Market
Estimation, 2015 – 2019
10.2.6.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By
Scope of Use
11. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
11.1. Overview
11.2. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
11.2.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2019
11.2.1.3. Market
Forecast, 2020 – 2028
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Refractory
Septic / Cardiogenic Shock
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2019
11.2.2.3. Market
Forecast, 2020 – 2028
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.2.3. Myocarditis
- viral, scorpion sting
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2019
11.2.3.3. Market
Forecast, 2020 – 2028
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2019
11.2.3.5.1.2. Market
Forecast, 2020 – 2028
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2019
11.2.3.5.2.2. Market
Forecast, 2020 – 2028
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2019
11.2.3.5.3.2. Market
Forecast, 2020 – 2028
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2019
11.2.3.5.4.2. Market
Forecast, 2020 – 2028
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2019
11.2.3.5.5.2. Market
Forecast, 2020 – 2028
11.2.4. Post
Arrest shock
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 – 2019
11.2.4.3. Market
Forecast, 2020 – 2028
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 – 2019
11.2.4.5.1.2. Market
Forecast, 2020 – 2028
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2019
11.2.4.5.2.2. Market
Forecast, 2020 – 2028
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2019
11.2.4.5.3.2. Market
Forecast, 2020 – 2028
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2019
11.2.4.5.4.2. Market
Forecast, 2020 – 2028
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 – 2019
11.2.4.5.5.2. Market
Forecast, 2020 – 2028
11.2.5. Meconium
Aspiration
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 – 2019
11.2.5.3. Market
Forecast, 2020 – 2028
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2015 – 2019
11.2.5.5.1.2. Market
Forecast, 2020 – 2028
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 – 2019
11.2.5.5.2.2. Market
Forecast, 2020 – 2028
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2015 – 2019
11.2.5.5.3.2. Market
Forecast, 2020 – 2028
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 – 2019
11.2.5.5.4.2. Market
Forecast, 2020 – 2028
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2015 – 2019
11.2.5.5.5.2. Market
Forecast, 2020 – 2028
11.2.6. Congenital
Diaphragmatic Hernia
11.2.6.1. Definition
11.2.6.2. Market
Estimation and Penetration, 2015 – 2019
11.2.6.3. Market
Forecast, 2020 – 2028
11.2.6.4. Compound
Annual Growth Rate (CAGR)
11.2.6.5. Regional
Bifurcation
11.2.6.5.1. North
America
11.2.6.5.1.1. Market
Estimation, 2015 – 2019
11.2.6.5.1.2. Market
Forecast, 2020 – 2028
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 – 2019
11.2.6.5.2.2. Market
Forecast, 2020 – 2028
11.2.6.5.3. Asia
Pacific
11.2.6.5.3.1. Market
Estimation, 2015 – 2019
11.2.6.5.3.2. Market
Forecast, 2020 – 2028
11.2.6.5.4. Middle
East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 – 2019
11.2.6.5.4.2. Market
Forecast, 2020 – 2028
11.2.6.5.5. Latin
America
11.2.6.5.5.1. Market
Estimation, 2015 – 2019
11.2.6.5.5.2. Market
Forecast, 2020 – 2028
11.2.7. Persistent
Pulmonary Hypertension
11.2.7.1. Definition
11.2.7.2. Market
Estimation and Penetration, 2015 – 2019
11.2.7.3. Market
Forecast, 2020 – 2028
11.2.7.4. Compound
Annual Growth Rate (CAGR)
11.2.7.5. Regional
Bifurcation
11.2.7.5.1. North
America
11.2.7.5.1.1. Market
Estimation, 2015 – 2019
11.2.7.5.1.2. Market
Forecast, 2020 – 2028
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 – 2019
11.2.7.5.2.2. Market
Forecast, 2020 – 2028
11.2.7.5.3. Asia
Pacific
11.2.7.5.3.1. Market
Estimation, 2015 – 2019
11.2.7.5.3.2. Market
Forecast, 2020 – 2028
11.2.7.5.4. Middle
East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 – 2019
11.2.7.5.4.2. Market
Forecast, 2020 – 2028
11.2.7.5.5. Latin
America
11.2.7.5.5.1. Market
Estimation, 2015 – 2019
11.2.7.5.5.2. Market
Forecast, 2020 – 2028
11.2.8. Swine
Flu infection (H1N1)
11.2.8.1. Definition
11.2.8.2. Market
Estimation and Penetration, 2015 – 2019
11.2.8.3. Market
Forecast, 2020 – 2028
11.2.8.4. Compound
Annual Growth Rate (CAGR)
11.2.8.5. Regional
Bifurcation
11.2.8.5.1. North
America
11.2.8.5.1.1. Market
Estimation, 2015 – 2019
11.2.8.5.1.2. Market
Forecast, 2020 – 2028
11.2.8.5.2. Europe
11.2.8.5.2.1. Market
Estimation, 2015 – 2019
11.2.8.5.2.2. Market
Forecast, 2020 – 2028
11.2.8.5.3. Asia
Pacific
11.2.8.5.3.1. Market
Estimation, 2015 – 2019
11.2.8.5.3.2. Market
Forecast, 2020 – 2028
11.2.8.5.4. Middle
East and Africa
11.2.8.5.4.1. Market
Estimation, 2015 – 2019
11.2.8.5.4.2. Market
Forecast, 2020 – 2028
11.2.8.5.5. Latin
America
11.2.8.5.5.1. Market
Estimation, 2015 – 2019
11.2.8.5.5.2. Market
Forecast, 2020 – 2028
11.2.9. COVID-19
11.2.9.1. Definition
11.2.9.2. Market
Estimation and Penetration, 2015 – 2019
11.2.9.3. Market
Forecast, 2020 – 2028
11.2.9.4. Compound
Annual Growth Rate (CAGR)
11.2.9.5. Regional
Bifurcation
11.2.9.5.1. North
America
11.2.9.5.1.1. Market
Estimation, 2015 – 2019
11.2.9.5.1.2. Market
Forecast, 2020 – 2028
11.2.9.5.2. Europe
11.2.9.5.2.1. Market
Estimation, 2015 – 2019
11.2.9.5.2.2. Market
Forecast, 2020 – 2028
11.2.9.5.3. Asia
Pacific
11.2.9.5.3.1. Market
Estimation, 2015 – 2019
11.2.9.5.3.2. Market
Forecast, 2020 – 2028
11.2.9.5.4. Middle
East and Africa
11.2.9.5.4.1. Market
Estimation, 2015 – 2019
11.2.9.5.4.2. Market
Forecast, 2020 – 2028
11.2.9.5.5. Latin
America
11.2.9.5.5.1. Market
Estimation, 2015 – 2019
11.2.9.5.5.2. Market
Forecast, 2020 – 2028
11.2.10. Poisoning
11.2.10.1. Definition
11.2.10.2. Market
Estimation and Penetration, 2015 – 2019
11.2.10.3. Market
Forecast, 2020 – 2028
11.2.10.4. Compound
Annual Growth Rate (CAGR)
11.2.10.5. Regional
Bifurcation
11.2.10.5.1. North
America
11.2.10.5.1.1. Market
Estimation, 2015 – 2019
11.2.10.5.1.2. Market
Forecast, 2020 – 2028
11.2.10.5.2. Europe
11.2.10.5.2.1. Market
Estimation, 2015 – 2019
11.2.10.5.2.2. Market
Forecast, 2020 – 2028
11.2.10.5.3. Asia
Pacific
11.2.10.5.3.1. Market
Estimation, 2015 – 2019
11.2.10.5.3.2. Market
Forecast, 2020 – 2028
11.2.10.5.4. Middle
East and Africa
11.2.10.5.4.1. Market
Estimation, 2015 – 2019
11.2.10.5.4.2. Market
Forecast, 2020 – 2028
11.2.10.5.5. Latin
America
11.2.10.5.5.1. Market
Estimation, 2015 – 2019
11.2.10.5.5.2. Market
Forecast, 2020 – 2028
11.2.11. Others
11.2.11.1. Definition
11.2.11.2. Market
Estimation and Penetration, 2015 – 2019
11.2.11.3. Market
Forecast, 2020 – 2028
11.2.11.4. Compound
Annual Growth Rate (CAGR)
11.2.11.5. Regional
Bifurcation
11.2.11.5.1. North
America
11.2.11.5.1.1. Market
Estimation, 2015 – 2019
11.2.11.5.1.2. Market
Forecast, 2020 – 2028
11.2.11.5.2. Europe
11.2.11.5.2.1. Market
Estimation, 2015 – 2019
11.2.11.5.2.2. Market
Forecast, 2020 – 2028
11.2.11.5.3. Asia
Pacific
11.2.11.5.3.1. Market
Estimation, 2015 – 2019
11.2.11.5.3.2. Market
Forecast, 2020 – 2028
11.2.11.5.4. Middle
East and Africa
11.2.11.5.4.1. Market
Estimation, 2015 – 2019
11.2.11.5.4.2. Market
Forecast, 2020 – 2028
11.2.11.5.5. Latin
America
11.2.11.5.5.1. Market
Estimation, 2015 – 2019
11.2.11.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key
Segment for Channeling Investments
11.3.1. By
Diseases
12. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
12.1. Overview
12.2. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
12.2.1. Online
12.2.1.1. Definition
12.2.1.2. Market
Estimation and Penetration, 2015 – 2019
12.2.1.3. Market
Forecast, 2020 – 2028
12.2.1.4. Compound
Annual Growth Rate (CAGR)
12.2.1.5. Regional
Bifurcation
12.2.1.5.1. North
America
12.2.1.5.1.1. Market
Estimation, 2015 – 2019
12.2.1.5.1.2. Market
Forecast, 2020 – 2028
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 – 2019
12.2.1.5.2.2. Market
Forecast, 2020 – 2028
12.2.1.5.3. Asia
Pacific
12.2.1.5.3.1. Market
Estimation, 2015 – 2019
12.2.1.5.3.2. Market
Forecast, 2020 – 2028
12.2.1.5.4. Middle
East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 – 2019
12.2.1.5.4.2. Market
Forecast, 2020 – 2028
12.2.1.5.5. Latin
America
12.2.1.5.5.1. Market
Estimation, 2015 – 2019
12.2.1.5.5.2. Market
Forecast, 2020 – 2028
12.2.2. Offline
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 – 2019
12.2.2.3. Market
Forecast, 2020 – 2028
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 – 2019
12.2.2.5.1.2. Market
Forecast, 2020 – 2028
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2019
12.2.2.5.2.2. Market
Forecast, 2020 – 2028
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2019
12.2.2.5.3.2. Market
Forecast, 2020 – 2028
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2019
12.2.2.5.4.2. Market
Forecast, 2020 – 2028
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 – 2019
12.2.2.5.5.2. Market
Forecast, 2020 – 2028
12.3. Key
Segment for Channeling Investments
12.3.1. By
Distribution Channel
13. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 – 2028
13.1. Overview
13.2. Global
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
13.2.1. Hospitals/Clinics
13.2.1.1. Definition
13.2.1.2. Market
Estimation and Penetration, 2015 – 2019
13.2.1.3. Market
Forecast, 2020 – 2028
13.2.1.4. Compound
Annual Growth Rate (CAGR)
13.2.1.5. Regional
Bifurcation
13.2.1.5.1. North
America
13.2.1.5.1.1. Market
Estimation, 2015 – 2019
13.2.1.5.1.2. Market
Forecast, 2020 – 2028
13.2.1.5.2. Europe
13.2.1.5.2.1. Market
Estimation, 2015 – 2019
13.2.1.5.2.2. Market
Forecast, 2020 – 2028
13.2.1.5.3. Asia
Pacific
13.2.1.5.3.1. Market
Estimation, 2015 – 2019
13.2.1.5.3.2. Market
Forecast, 2020 – 2028
13.2.1.5.4. Middle
East and Africa
13.2.1.5.4.1. Market
Estimation, 2015 – 2019
13.2.1.5.4.2. Market
Forecast, 2020 – 2028
13.2.1.5.5. Latin
America
13.2.1.5.5.1. Market
Estimation, 2015 – 2019
13.2.1.5.5.2. Market
Forecast, 2020 – 2028
13.2.2. Research
Centers
13.2.2.1. Definition
13.2.2.2. Market
Estimation and Penetration, 2015 – 2019
13.2.2.3. Market
Forecast, 2020 – 2028
13.2.2.4. Compound
Annual Growth Rate (CAGR)
13.2.2.5. Regional
Bifurcation
13.2.2.5.1. North
America
13.2.2.5.1.1. Market
Estimation, 2015 – 2019
13.2.2.5.1.2. Market
Forecast, 2020 – 2028
13.2.2.5.2. Europe
13.2.2.5.2.1. Market
Estimation, 2015 – 2019
13.2.2.5.2.2. Market
Forecast, 2020 – 2028
13.2.2.5.3. Asia
Pacific
13.2.2.5.3.1. Market
Estimation, 2015 – 2019
13.2.2.5.3.2. Market
Forecast, 2020 – 2028
13.2.2.5.4. Middle
East and Africa
13.2.2.5.4.1. Market
Estimation, 2015 – 2019
13.2.2.5.4.2. Market
Forecast, 2020 – 2028
13.2.2.5.5. Latin
America
13.2.2.5.5.1. Market
Estimation, 2015 – 2019
13.2.2.5.5.2. Market
Forecast, 2020 – 2028
13.2.3. Others
13.2.3.1. Definition
13.2.3.2. Market
Estimation and Penetration, 2015 – 2019
13.2.3.3. Market
Forecast, 2020 – 2028
13.2.3.4. Compound
Annual Growth Rate (CAGR)
13.2.3.5. Regional
Bifurcation
13.2.3.5.1. North
America
13.2.3.5.1.1. Market
Estimation, 2015 – 2019
13.2.3.5.1.2. Market
Forecast, 2020 – 2028
13.2.3.5.2. Europe
13.2.3.5.2.1. Market
Estimation, 2015 – 2019
13.2.3.5.2.2. Market
Forecast, 2020 – 2028
13.2.3.5.3. Asia
Pacific
13.2.3.5.3.1. Market
Estimation, 2015 – 2019
13.2.3.5.3.2. Market
Forecast, 2020 – 2028
13.2.3.5.4. Middle
East and Africa
13.2.3.5.4.1. Market
Estimation, 2015 – 2019
13.2.3.5.4.2. Market
Forecast, 2020 – 2028
13.2.3.5.5. Latin
America
13.2.3.5.5.1. Market
Estimation, 2015 – 2019
13.2.3.5.5.2. Market
Forecast, 2020 – 2028
13.3. Key
Segment for Channeling Investments
13.3.1. By End
Users
14. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 - 2028
14.1. Overview
14.1.1. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn)
14.2. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
14.2.1. Integrated
Systems
14.2.2. Components
14.2.2.1. Oxygenators
14.2.2.2. Catheter
14.2.2.3. Heat
Exchangers
14.2.2.4. Pumps
14.2.2.5. Tubing
Kits
14.2.2.6. Back-up
Battery
14.2.2.7. Others
14.2.3. Integrated
Sensors
14.3. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
14.3.1. VA ECMO
14.3.2. VV ECMO
14.4. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
14.4.1. Intensive
care
14.4.2. Operation
Theatres
14.4.3. Emergency
Medicine
14.4.4. Cardiology
14.4.5. Cardiac
Surgery
14.4.6. Others
14.5. North America
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
14.5.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
14.5.2. Refractory
Septic / Cardiogenic Shock
14.5.3. Myocarditis
- viral, scorpion sting
14.5.4. Post
Arrest shock
14.5.5. Meconium
Aspiration
14.5.6. Congenital
Diaphragmatic Hernia
14.5.7. Persistent
Pulmonary Hypertension
14.5.8. Swine
Flu infection (H1N1)
14.5.9. COVID-19
14.5.10. Poisoning
14.5.11. Others
14.6. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
14.6.1. Online
14.6.2. Offline
14.7. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
14.7.1. Hospitals/Clinics
14.7.2. Research
Centers
14.7.3. Others
14.8. North
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Country
14.8.1. U.S
14.8.1.1. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.8.1.1.1. Integrated
Systems
14.8.1.1.2. Components
14.8.1.1.2.1. Oxygenators
14.8.1.1.2.2. Catheter
14.8.1.1.2.3. Heat
Exchangers
14.8.1.1.2.4. Pumps
14.8.1.1.2.5. Tubing
Kits
14.8.1.1.2.6. Back-up
Battery
14.8.1.1.2.7. Others
14.8.1.1.3. Integrated
Sensors
14.8.1.2. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
14.8.1.2.1. VA
ECMO
14.8.1.2.2. VV
ECMO
14.8.1.3. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
14.8.1.3.1. Intensive
care
14.8.1.3.2. Operation
Theatres
14.8.1.3.3. Emergency
Medicine
14.8.1.3.4. Cardiology
14.8.1.3.5. Cardiac
Surgery
14.8.1.3.6. Others
14.8.1.4. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
14.8.1.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
14.8.1.4.2. Refractory
Septic / Cardiogenic Shock
14.8.1.4.3. Myocarditis
- viral, scorpion sting
14.8.1.4.4. Post
Arrest shock
14.8.1.4.5. Meconium
Aspiration
14.8.1.4.6. Congenital
Diaphragmatic Hernia
14.8.1.4.7. Persistent
Pulmonary Hypertension
14.8.1.4.8. Swine
Flu infection (H1N1)
14.8.1.4.9. COVID-19
14.8.1.4.10. Poisoning
14.8.1.4.11. Others
14.8.1.5. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.8.1.5.1. Online
14.8.1.5.2. Offline
14.8.1.6. U.S
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.8.1.6.1. Hospitals/Clinics
14.8.1.6.2. Research
Centers
14.8.1.6.3. Others
14.8.2. Canada
14.8.2.1. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.8.2.1.1. Integrated
Systems
14.8.2.1.2. Components
14.8.2.1.2.1. Oxygenators
14.8.2.1.2.2. Catheter
14.8.2.1.2.3. Heat
Exchangers
14.8.2.1.2.4. Pumps
14.8.2.1.2.5. Tubing
Kits
14.8.2.1.2.6. Back-up
Battery
14.8.2.1.2.7. Others
14.8.2.1.3. Integrated
Sensors
14.8.2.2. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
14.8.2.2.1. VA
ECMO
14.8.2.2.2. VV
ECMO
14.8.2.3. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
14.8.2.3.1. Intensive
care
14.8.2.3.2. Operation
Theatres
14.8.2.3.3. Emergency
Medicine
14.8.2.3.4. Cardiology
14.8.2.3.5. Cardiac
Surgery
14.8.2.3.6. Others
14.8.2.4. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
14.8.2.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
14.8.2.4.2. Refractory
Septic / Cardiogenic Shock
14.8.2.4.3. Myocarditis
- viral, scorpion sting
14.8.2.4.4. Post
Arrest shock
14.8.2.4.5. Meconium
Aspiration
14.8.2.4.6. Congenital
Diaphragmatic Hernia
14.8.2.4.7. Persistent
Pulmonary Hypertension
14.8.2.4.8. Swine
Flu infection (H1N1)
14.8.2.4.9. COVID-19
14.8.2.4.10. Poisoning
14.8.2.4.11. Others
14.8.2.5. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.8.2.5.1. Online
14.8.2.5.2. Offline
14.8.2.6. Canada
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.8.2.6.1. Hospitals/Clinics
14.8.2.6.2. Research
Centers
14.8.2.6.3. Others
14.8.3. Mexico
14.8.3.1. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.8.3.1.1. Integrated
Systems
14.8.3.1.2. Components
14.8.3.1.2.1. Oxygenators
14.8.3.1.2.2. Catheter
14.8.3.1.2.3. Heat
Exchangers
14.8.3.1.2.4. Pumps
14.8.3.1.2.5. Tubing
Kits
14.8.3.1.2.6. Back-up
Battery
14.8.3.1.2.7. Others
14.8.3.1.3. Integrated
Sensors
14.8.3.2. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
14.8.3.2.1. VA
ECMO
14.8.3.2.2. VV
ECMO
14.8.3.3. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
14.8.3.3.1. Intensive
care
14.8.3.3.2. Operation
Theatres
14.8.3.3.3. Emergency
Medicine
14.8.3.3.4. Cardiology
14.8.3.3.5. Cardiac
Surgery
14.8.3.3.6. Others
14.8.3.4. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
14.8.3.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
14.8.3.4.2. Refractory
Septic / Cardiogenic Shock
14.8.3.4.3. Myocarditis
- viral, scorpion sting
14.8.3.4.4. Post
Arrest shock
14.8.3.4.5. Meconium
Aspiration
14.8.3.4.6. Congenital
Diaphragmatic Hernia
14.8.3.4.7. Persistent
Pulmonary Hypertension
14.8.3.4.8. Swine
Flu infection (H1N1)
14.8.3.4.9. COVID-19
14.8.3.4.10. Poisoning
14.8.3.4.11. Others
14.8.3.5. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
14.8.3.5.1. Online
14.8.3.5.2. Offline
14.8.3.6. Mexico
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
14.8.3.6.1. Hospitals/Clinics
14.8.3.6.2. Research
Centers
14.8.3.6.3. Others
14.8.4. Rest of
North America
14.8.4.1. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.8.4.1.1. Integrated
Systems
14.8.4.1.2. Components
14.8.4.1.2.1. Oxygenators
14.8.4.1.2.2. Catheter
14.8.4.1.2.3. Heat
Exchangers
14.8.4.1.2.4. Pumps
14.8.4.1.2.5. Tubing
Kits
14.8.4.1.2.6. Back-up
Battery
14.8.4.1.2.7. Others
14.8.4.1.3. Integrated
Sensors
14.8.4.2. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By System Type
14.8.4.2.1. VA
ECMO
14.8.4.2.2. VV
ECMO
14.8.4.3. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Scope of Use
14.8.4.3.1. Intensive
care
14.8.4.3.2. Operation
Theatres
14.8.4.3.3. Emergency
Medicine
14.8.4.3.4. Cardiology
14.8.4.3.5. Cardiac
Surgery
14.8.4.3.6. Others
14.8.4.4. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Diseases
14.8.4.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
14.8.4.4.2. Refractory
Septic / Cardiogenic Shock
14.8.4.4.3. Myocarditis
- viral, scorpion sting
14.8.4.4.4. Post
Arrest shock
14.8.4.4.5. Meconium
Aspiration
14.8.4.4.6. Congenital
Diaphragmatic Hernia
14.8.4.4.7. Persistent
Pulmonary Hypertension
14.8.4.4.8. Swine
Flu infection (H1N1)
14.8.4.4.9. COVID-19
14.8.4.4.10. Poisoning
14.8.4.4.11. Others
14.8.4.5. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
14.8.4.5.1. Online
14.8.4.5.2. Offline
14.8.4.6. Rest
of North America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By End Users
14.8.4.6.1. Hospitals/Clinics
14.8.4.6.2. Research
Centers
14.8.4.6.3. Others
14.9. Key
Segment for Channeling Investments
14.9.1. By
Country
14.9.2. By
Offerings
14.9.3. By
System Type
14.9.4. By
Scope of Use
14.9.5. By
Diseases
14.9.6. By
Distribution Channel
14.9.7. By End
Users
15. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
15.2. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.2.1. Integrated
Systems
15.2.2. Components
15.2.2.1. Oxygenators
15.2.2.2. Catheter
15.2.2.3. Heat
Exchangers
15.2.2.4. Pumps
15.2.2.5. Tubing
Kits
15.2.2.6. Back-up
Battery
15.2.2.7. Others
15.2.3. Integrated
Sensors
15.3. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
15.3.1. VA ECMO
15.3.2. VV ECMO
15.4. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
15.4.1. Intensive
care
15.4.2. Operation
Theatres
15.4.3. Emergency
Medicine
15.4.4. Cardiology
15.4.5. Cardiac
Surgery
15.4.6. Others
15.5. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
15.5.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.5.2. Refractory
Septic / Cardiogenic Shock
15.5.3. Myocarditis
- viral, scorpion sting
15.5.4. Post
Arrest shock
15.5.5. Meconium
Aspiration
15.5.6. Congenital
Diaphragmatic Hernia
15.5.7. Persistent
Pulmonary Hypertension
15.5.8. Swine
Flu infection (H1N1)
15.5.9. COVID-19
15.5.10. Poisoning
15.5.11. Others
15.6. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.6.1. Online
15.6.2. Offline
15.7. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.1. Hospitals/Clinics
15.7.2. Research
Centers
15.7.3. Others
15.8. Europe
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Country
15.8.1. France
15.8.1.1. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.8.1.1.1. Integrated
Systems
15.8.1.1.2. Components
15.8.1.1.2.1. Oxygenators
15.8.1.1.2.2. Catheter
15.8.1.1.2.3. Heat
Exchangers
15.8.1.1.2.4. Pumps
15.8.1.1.2.5. Tubing
Kits
15.8.1.1.2.6. Back-up
Battery
15.8.1.1.2.7. Others
15.8.1.1.3. Integrated
Sensors
15.8.1.2. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
15.8.1.2.1. VA
ECMO
15.8.1.2.2. VV
ECMO
15.8.1.3. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
15.8.1.3.1. Intensive
care
15.8.1.3.2. Operation
Theatres
15.8.1.3.3. Emergency
Medicine
15.8.1.3.4. Cardiology
15.8.1.3.5. Cardiac
Surgery
15.8.1.3.6. Others
15.8.1.4. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
15.8.1.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.1.4.2. Refractory
Septic / Cardiogenic Shock
15.8.1.4.3. Myocarditis
- viral, scorpion sting
15.8.1.4.4. Post
Arrest shock
15.8.1.4.5. Meconium
Aspiration
15.8.1.4.6. Congenital
Diaphragmatic Hernia
15.8.1.4.7. Persistent
Pulmonary Hypertension
15.8.1.4.8. Swine
Flu infection (H1N1)
15.8.1.4.9. COVID-19
15.8.1.4.10. Poisoning
15.8.1.4.11. Others
15.8.1.5. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.1.5.1. Online
15.8.1.5.2. Offline
15.8.1.6. France
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.1.6.1. Hospitals/Clinics
15.8.1.6.2. Research
Centers
15.8.1.6.3. Others
15.8.2. The UK
15.8.2.1. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.8.2.1.1. Integrated
Systems
15.8.2.1.2. Components
15.8.2.1.2.1. Oxygenators
15.8.2.1.2.2. Catheter
15.8.2.1.2.3. Heat
Exchangers
15.8.2.1.2.4. Pumps
15.8.2.1.2.5. Tubing
Kits
15.8.2.1.2.6. Back-up
Battery
15.8.2.1.2.7. Others
15.8.2.1.3. Integrated
Sensors
15.8.2.2. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By System Type
15.8.2.2.1. VA
ECMO
15.8.2.2.2. VV
ECMO
15.8.2.3. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Scope of Use
15.8.2.3.1. Intensive
care
15.8.2.3.2. Operation
Theatres
15.8.2.3.3. Emergency
Medicine
15.8.2.3.4. Cardiology
15.8.2.3.5. Cardiac
Surgery
15.8.2.3.6. Others
15.8.2.4. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Diseases
15.8.2.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.2.4.2. Refractory
Septic / Cardiogenic Shock
15.8.2.4.3. Myocarditis
- viral, scorpion sting
15.8.2.4.4. Post
Arrest shock
15.8.2.4.5. Meconium
Aspiration
15.8.2.4.6. Congenital
Diaphragmatic Hernia
15.8.2.4.7. Persistent
Pulmonary Hypertension
15.8.2.4.8. Swine
Flu infection (H1N1)
15.8.2.4.9. COVID-19
15.8.2.4.10. Poisoning
15.8.2.4.11. Others
15.8.2.5. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
15.8.2.5.1. Online
15.8.2.5.2. Offline
15.8.2.6. The
UK Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
15.8.2.6.1. Hospitals/Clinics
15.8.2.6.2. Research
Centers
15.8.2.6.3. Others
15.8.3. Spain
15.8.3.1. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.8.3.1.1. Integrated
Systems
15.8.3.1.2. Components
15.8.3.1.2.1. Oxygenators
15.8.3.1.2.2. Catheter
15.8.3.1.2.3. Heat
Exchangers
15.8.3.1.2.4. Pumps
15.8.3.1.2.5. Tubing
Kits
15.8.3.1.2.6. Back-up
Battery
15.8.3.1.2.7. Others
15.8.3.1.3. Integrated
Sensors
15.8.3.2. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
15.8.3.2.1. VA
ECMO
15.8.3.2.2. VV
ECMO
15.8.3.3. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
15.8.3.3.1. Intensive
care
15.8.3.3.2. Operation
Theatres
15.8.3.3.3. Emergency
Medicine
15.8.3.3.4. Cardiology
15.8.3.3.5. Cardiac
Surgery
15.8.3.3.6. Others
15.8.3.4. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
15.8.3.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.3.4.2. Refractory
Septic / Cardiogenic Shock
15.8.3.4.3. Myocarditis
- viral, scorpion sting
15.8.3.4.4. Post
Arrest shock
15.8.3.4.5. Meconium
Aspiration
15.8.3.4.6. Congenital
Diaphragmatic Hernia
15.8.3.4.7. Persistent
Pulmonary Hypertension
15.8.3.4.8. Swine
Flu infection (H1N1)
15.8.3.4.9. COVID-19
15.8.3.4.10. Poisoning
15.8.3.4.11. Others
15.8.3.5. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.3.5.1. Online
15.8.3.5.2. Offline
15.8.3.6. Spain
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.3.6.1. Hospitals/Clinics
15.8.3.6.2. Research
Centers
15.8.3.6.3. Others
15.8.4. Germany
15.8.4.1. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.8.4.1.1. Integrated
Systems
15.8.4.1.2. Components
15.8.4.1.2.1. Oxygenators
15.8.4.1.2.2. Catheter
15.8.4.1.2.3. Heat
Exchangers
15.8.4.1.2.4. Pumps
15.8.4.1.2.5. Tubing
Kits
15.8.4.1.2.6. Back-up
Battery
15.8.4.1.2.7. Others
15.8.4.1.3. Integrated
Sensors
15.8.4.2. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
15.8.4.2.1. VA
ECMO
15.8.4.2.2. VV
ECMO
15.8.4.3. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
15.8.4.3.1. Intensive
care
15.8.4.3.2. Operation
Theatres
15.8.4.3.3. Emergency
Medicine
15.8.4.3.4. Cardiology
15.8.4.3.5. Cardiac
Surgery
15.8.4.3.6. Others
15.8.4.4. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
15.8.4.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.4.4.2. Refractory
Septic / Cardiogenic Shock
15.8.4.4.3. Myocarditis
- viral, scorpion sting
15.8.4.4.4. Post
Arrest shock
15.8.4.4.5. Meconium
Aspiration
15.8.4.4.6. Congenital
Diaphragmatic Hernia
15.8.4.4.7. Persistent
Pulmonary Hypertension
15.8.4.4.8. Swine
Flu infection (H1N1)
15.8.4.4.9. COVID-19
15.8.4.4.10. Poisoning
15.8.4.4.11. Others
15.8.4.5. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.4.5.1. Online
15.8.4.5.2. Offline
15.8.4.6. Germany
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.4.6.1. Hospitals/Clinics
15.8.4.6.2. Research
Centers
15.8.4.6.3. Others
15.8.5. Italy
15.8.5.1. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.8.5.1.1. Integrated
Systems
15.8.5.1.2. Components
15.8.5.1.2.1. Oxygenators
15.8.5.1.2.2. Catheter
15.8.5.1.2.3. Heat
Exchangers
15.8.5.1.2.4. Pumps
15.8.5.1.2.5. Tubing
Kits
15.8.5.1.2.6. Back-up
Battery
15.8.5.1.2.7. Others
15.8.5.1.3. Integrated
Sensors
15.8.5.2. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
15.8.5.2.1. VA
ECMO
15.8.5.2.2. VV
ECMO
15.8.5.3. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
15.8.5.3.1. Intensive
care
15.8.5.3.2. Operation
Theatres
15.8.5.3.3. Emergency
Medicine
15.8.5.3.4. Cardiology
15.8.5.3.5. Cardiac
Surgery
15.8.5.3.6. Others
15.8.5.4. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
15.8.5.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.5.4.2. Refractory
Septic / Cardiogenic Shock
15.8.5.4.3. Myocarditis
- viral, scorpion sting
15.8.5.4.4. Post
Arrest shock
15.8.5.4.5. Meconium
Aspiration
15.8.5.4.6. Congenital
Diaphragmatic Hernia
15.8.5.4.7. Persistent
Pulmonary Hypertension
15.8.5.4.8. Swine
Flu infection (H1N1)
15.8.5.4.9. COVID-19
15.8.5.4.10. Poisoning
15.8.5.4.11. Others
15.8.5.5. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
15.8.5.5.1. Online
15.8.5.5.2. Offline
15.8.5.6. Italy
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
15.8.5.6.1. Hospitals/Clinics
15.8.5.6.2. Research
Centers
15.8.5.6.3. Others
15.8.6. Nordic
Countries
15.8.6.1. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Offerings
15.8.6.1.1. Integrated
Systems
15.8.6.1.2. Components
15.8.6.1.2.1. Oxygenators
15.8.6.1.2.2. Catheter
15.8.6.1.2.3. Heat
Exchangers
15.8.6.1.2.4. Pumps
15.8.6.1.2.5. Tubing
Kits
15.8.6.1.2.6. Back-up
Battery
15.8.6.1.2.7. Others
15.8.6.1.3. Integrated
Sensors
15.8.6.2. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By System Type
15.8.6.2.1. VA
ECMO
15.8.6.2.2. VV
ECMO
15.8.6.3. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Scope of Use
15.8.6.3.1. Intensive
care
15.8.6.3.2. Operation
Theatres
15.8.6.3.3. Emergency
Medicine
15.8.6.3.4. Cardiology
15.8.6.3.5. Cardiac
Surgery
15.8.6.3.6. Others
15.8.6.4. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Diseases
15.8.6.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.6.4.2. Refractory
Septic / Cardiogenic Shock
15.8.6.4.3. Myocarditis
- viral, scorpion sting
15.8.6.4.4. Post
Arrest shock
15.8.6.4.5. Meconium
Aspiration
15.8.6.4.6. Congenital
Diaphragmatic Hernia
15.8.6.4.7. Persistent
Pulmonary Hypertension
15.8.6.4.8. Swine
Flu infection (H1N1)
15.8.6.4.9. COVID-19
15.8.6.4.10. Poisoning
15.8.6.4.11. Others
15.8.6.5. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
15.8.6.5.1. Online
15.8.6.5.2. Offline
15.8.6.6. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By End Users
15.8.6.6.1. Hospitals/Clinics
15.8.6.6.2. Research
Centers
15.8.6.6.3. Others
15.8.6.7. Nordic
Countries Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Country
15.8.6.7.1. Denmark
15.8.6.7.2. Finland
15.8.6.7.3. Iceland
15.8.6.7.4. Sweden
15.8.6.7.5. Norway
15.8.7. Benelux
Union
15.8.7.1. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
15.8.7.1.1. Integrated
Systems
15.8.7.1.2. Components
15.8.7.1.2.1. Oxygenators
15.8.7.1.2.2. Catheter
15.8.7.1.2.3. Heat
Exchangers
15.8.7.1.2.4. Pumps
15.8.7.1.2.5. Tubing
Kits
15.8.7.1.2.6. Back-up
Battery
15.8.7.1.2.7. Others
15.8.7.1.3. Integrated
Sensors
15.8.7.2. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
15.8.7.2.1. VA
ECMO
15.8.7.2.2. VV
ECMO
15.8.7.3. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
15.8.7.3.1. Intensive
care
15.8.7.3.2. Operation
Theatres
15.8.7.3.3. Emergency
Medicine
15.8.7.3.4. Cardiology
15.8.7.3.5. Cardiac
Surgery
15.8.7.3.6. Others
15.8.7.4. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
15.8.7.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.7.4.2. Refractory
Septic / Cardiogenic Shock
15.8.7.4.3. Myocarditis
- viral, scorpion sting
15.8.7.4.4. Post
Arrest shock
15.8.7.4.5. Meconium
Aspiration
15.8.7.4.6. Congenital
Diaphragmatic Hernia
15.8.7.4.7. Persistent
Pulmonary Hypertension
15.8.7.4.8. Swine
Flu infection (H1N1)
15.8.7.4.9. COVID-19
15.8.7.4.10. Poisoning
15.8.7.4.11. Others
15.8.7.5. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
15.8.7.5.1. Online
15.8.7.5.2. Offline
15.8.7.6. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
15.8.7.6.1. Hospitals/Clinics
15.8.7.6.2. Research
Centers
15.8.7.6.3. Others
15.8.7.7. Benelux
Union Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Country
15.8.7.7.1. Belgium
15.8.7.7.2. The
Netherlands
15.8.7.7.3. Luxembourg
15.8.8. Rest of
Europe
15.8.8.1. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Offerings
15.8.8.1.1. Integrated
Systems
15.8.8.1.2. Components
15.8.8.1.2.1. Oxygenators
15.8.8.1.2.2. Catheter
15.8.8.1.2.3. Heat
Exchangers
15.8.8.1.2.4. Pumps
15.8.8.1.2.5. Tubing
Kits
15.8.8.1.2.6. Back-up
Battery
15.8.8.1.2.7. Others
15.8.8.1.3. Integrated
Sensors
15.8.8.2. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By System Type
15.8.8.2.1. VA
ECMO
15.8.8.2.2. VV
ECMO
15.8.8.3. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Scope of Use
15.8.8.3.1. Intensive
care
15.8.8.3.2. Operation
Theatres
15.8.8.3.3. Emergency
Medicine
15.8.8.3.4. Cardiology
15.8.8.3.5. Cardiac
Surgery
15.8.8.3.6. Others
15.8.8.4. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Diseases
15.8.8.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
15.8.8.4.2. Refractory
Septic / Cardiogenic Shock
15.8.8.4.3. Myocarditis
- viral, scorpion sting
15.8.8.4.4. Post
Arrest shock
15.8.8.4.5. Meconium
Aspiration
15.8.8.4.6. Congenital
Diaphragmatic Hernia
15.8.8.4.7. Persistent
Pulmonary Hypertension
15.8.8.4.8. Swine
Flu infection (H1N1)
15.8.8.4.9. COVID-19
15.8.8.4.10. Poisoning
15.8.8.4.11. Others
15.8.8.5. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By Distribution Channel
15.8.8.5.1. Online
15.8.8.5.2. Offline
15.8.8.6. Rest
of Europe Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue
(US$ Mn) and Forecasts, By End Users
15.8.8.6.1. Hospitals/Clinics
15.8.8.6.2. Research
Centers
15.8.8.6.3. Others
15.9. Key
Segment for Channeling Investments
15.9.1. By
Country
15.9.2. By
Offerings
15.9.3. By
System Type
15.9.4. By
Scope of Use
15.9.5. By
Diseases
15.9.6. By
Distribution Channel
15.9.7. By End
Users
16. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn)
16.2. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
16.2.1. Integrated
Systems
16.2.2. Components
16.2.2.1. Oxygenators
16.2.2.2. Catheter
16.2.2.3. Heat
Exchangers
16.2.2.4. Pumps
16.2.2.5. Tubing
Kits
16.2.2.6. Back-up
Battery
16.2.2.7. Others
16.2.3. Integrated
Sensors
16.3. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
16.3.1. VA ECMO
16.3.2. VV ECMO
16.4. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
16.4.1. Intensive
care
16.4.2. Operation
Theatres
16.4.3. Emergency
Medicine
16.4.4. Cardiology
16.4.5. Cardiac
Surgery
16.4.6. Others
16.5. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
16.5.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.5.2. Refractory
Septic / Cardiogenic Shock
16.5.3. Myocarditis
- viral, scorpion sting
16.5.4. Post
Arrest shock
16.5.5. Meconium
Aspiration
16.5.6. Congenital
Diaphragmatic Hernia
16.5.7. Persistent
Pulmonary Hypertension
16.5.8. Swine
Flu infection (H1N1)
16.5.9. COVID-19
16.5.10. Poisoning
16.5.11. Others
16.6. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
16.6.1. Online
16.6.2. Offline
16.7. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
16.7.1. Hospitals/Clinics
16.7.2. Research
Centers
16.7.3. Others
16.8. Asia
Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Country
16.8.1. China
16.8.1.1. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.8.1.1.1. Integrated
Systems
16.8.1.1.2. Components
16.8.1.1.2.1. Oxygenators
16.8.1.1.2.2. Catheter
16.8.1.1.2.3. Heat
Exchangers
16.8.1.1.2.4. Pumps
16.8.1.1.2.5. Tubing
Kits
16.8.1.1.2.6. Back-up
Battery
16.8.1.1.2.7. Others
16.8.1.1.3. Integrated
Sensors
16.8.1.2. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
16.8.1.2.1. VA
ECMO
16.8.1.2.2. VV
ECMO
16.8.1.3. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
16.8.1.3.1. Intensive
care
16.8.1.3.2. Operation
Theatres
16.8.1.3.3. Emergency
Medicine
16.8.1.3.4. Cardiology
16.8.1.3.5. Cardiac
Surgery
16.8.1.3.6. Others
16.8.1.4. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
16.8.1.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.1.4.2. Refractory
Septic / Cardiogenic Shock
16.8.1.4.3. Myocarditis
- viral, scorpion sting
16.8.1.4.4. Post
Arrest shock
16.8.1.4.5. Meconium
Aspiration
16.8.1.4.6. Congenital
Diaphragmatic Hernia
16.8.1.4.7. Persistent
Pulmonary Hypertension
16.8.1.4.8. Swine
Flu infection (H1N1)
16.8.1.4.9. COVID-19
16.8.1.4.10. Poisoning
16.8.1.4.11. Others
16.8.1.5. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.1.5.1. Online
16.8.1.5.2. Offline
16.8.1.6. China
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.1.6.1. Hospitals/Clinics
16.8.1.6.2. Research
Centers
16.8.1.6.3. Others
16.8.2. Japan
16.8.2.1. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.8.2.1.1. Integrated
Systems
16.8.2.1.2. Components
16.8.2.1.2.1. Oxygenators
16.8.2.1.2.2. Catheter
16.8.2.1.2.3. Heat
Exchangers
16.8.2.1.2.4. Pumps
16.8.2.1.2.5. Tubing
Kits
16.8.2.1.2.6. Back-up
Battery
16.8.2.1.2.7. Others
16.8.2.1.3. Integrated
Sensors
16.8.2.2. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
16.8.2.2.1. VA
ECMO
16.8.2.2.2. VV
ECMO
16.8.2.3. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
16.8.2.3.1. Intensive
care
16.8.2.3.2. Operation
Theatres
16.8.2.3.3. Emergency
Medicine
16.8.2.3.4. Cardiology
16.8.2.3.5. Cardiac
Surgery
16.8.2.3.6. Others
16.8.2.4. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
16.8.2.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.2.4.2. Refractory
Septic / Cardiogenic Shock
16.8.2.4.3. Myocarditis
- viral, scorpion sting
16.8.2.4.4. Post
Arrest shock
16.8.2.4.5. Meconium
Aspiration
16.8.2.4.6. Congenital
Diaphragmatic Hernia
16.8.2.4.7. Persistent
Pulmonary Hypertension
16.8.2.4.8. Swine
Flu infection (H1N1)
16.8.2.4.9. COVID-19
16.8.2.4.10. Poisoning
16.8.2.4.11. Others
16.8.2.5. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.2.5.1. Online
16.8.2.5.2. Offline
16.8.2.6. Japan
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.2.6.1. Hospitals/Clinics
16.8.2.6.2. Research
Centers
16.8.2.6.3. Others
16.8.3. India
16.8.3.1. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.8.3.1.1. Integrated
Systems
16.8.3.1.2. Components
16.8.3.1.2.1. Oxygenators
16.8.3.1.2.2. Catheter
16.8.3.1.2.3. Heat
Exchangers
16.8.3.1.2.4. Pumps
16.8.3.1.2.5. Tubing
Kits
16.8.3.1.2.6. Back-up
Battery
16.8.3.1.2.7. Others
16.8.3.1.3. Integrated
Sensors
16.8.3.2. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
16.8.3.2.1. VA
ECMO
16.8.3.2.2. VV
ECMO
16.8.3.3. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
16.8.3.3.1. Intensive
care
16.8.3.3.2. Operation
Theatres
16.8.3.3.3. Emergency
Medicine
16.8.3.3.4. Cardiology
16.8.3.3.5. Cardiac
Surgery
16.8.3.3.6. Others
16.8.3.4. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
16.8.3.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.3.4.2. Refractory
Septic / Cardiogenic Shock
16.8.3.4.3. Myocarditis
- viral, scorpion sting
16.8.3.4.4. Post
Arrest shock
16.8.3.4.5. Meconium
Aspiration
16.8.3.4.6. Congenital
Diaphragmatic Hernia
16.8.3.4.7. Persistent
Pulmonary Hypertension
16.8.3.4.8. Swine
Flu infection (H1N1)
16.8.3.4.9. COVID-19
16.8.3.4.10. Poisoning
16.8.3.4.11. Others
16.8.3.5. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.3.5.1. Online
16.8.3.5.2. Offline
16.8.3.6. India
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.3.6.1. Hospitals/Clinics
16.8.3.6.2. Research
Centers
16.8.3.6.3. Others
16.8.4. New
Zealand
16.8.4.1. New
Zealand Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
16.8.4.1.1. Integrated
Systems
16.8.4.1.2. Components
16.8.4.1.2.1. Oxygenators
16.8.4.1.2.2. Catheter
16.8.4.1.2.3. Heat
Exchangers
16.8.4.1.2.4. Pumps
16.8.4.1.2.5. Tubing
Kits
16.8.4.1.2.6. Back-up
Battery
16.8.4.1.2.7. Others
16.8.4.1.3. Integrated
Sensors
16.8.4.2. New
Zealand Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
16.8.4.2.1. VA
ECMO
16.8.4.2.2. VV
ECMO
16.8.4.3. New
Zealand Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
16.8.4.3.1. Intensive
care
16.8.4.3.2. Operation
Theatres
16.8.4.3.3. Emergency
Medicine
16.8.4.3.4. Cardiology
16.8.4.3.5. Cardiac
Surgery
16.8.4.3.6. Others
16.8.4.4. New Zealand
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
16.8.4.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.4.4.2. Refractory
Septic / Cardiogenic Shock
16.8.4.4.3. Myocarditis
- viral, scorpion sting
16.8.4.4.4. Post
Arrest shock
16.8.4.4.5. Meconium
Aspiration
16.8.4.4.6. Congenital
Diaphragmatic Hernia
16.8.4.4.7. Persistent
Pulmonary Hypertension
16.8.4.4.8. Swine
Flu infection (H1N1)
16.8.4.4.9. COVID-19
16.8.4.4.10. Poisoning
16.8.4.4.11. Others
16.8.4.5. New
Zealand Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
16.8.4.5.1. Online
16.8.4.5.2. Offline
16.8.4.6. New
Zealand Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
16.8.4.6.1. Hospitals/Clinics
16.8.4.6.2. Research
Centers
16.8.4.6.3. Others
16.8.5. Australia
16.8.5.1. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.8.5.1.1. Integrated
Systems
16.8.5.1.2. Components
16.8.5.1.2.1. Oxygenators
16.8.5.1.2.2. Catheter
16.8.5.1.2.3. Heat
Exchangers
16.8.5.1.2.4. Pumps
16.8.5.1.2.5. Tubing
Kits
16.8.5.1.2.6. Back-up
Battery
16.8.5.1.2.7. Others
16.8.5.1.3. Integrated
Sensors
16.8.5.2. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
16.8.5.2.1. VA
ECMO
16.8.5.2.2. VV
ECMO
16.8.5.3. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
16.8.5.3.1. Intensive
care
16.8.5.3.2. Operation
Theatres
16.8.5.3.3. Emergency
Medicine
16.8.5.3.4. Cardiology
16.8.5.3.5. Cardiac
Surgery
16.8.5.3.6. Others
16.8.5.4. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
16.8.5.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.5.4.2. Refractory
Septic / Cardiogenic Shock
16.8.5.4.3. Myocarditis
- viral, scorpion sting
16.8.5.4.4. Post
Arrest shock
16.8.5.4.5. Meconium
Aspiration
16.8.5.4.6. Congenital
Diaphragmatic Hernia
16.8.5.4.7. Persistent
Pulmonary Hypertension
16.8.5.4.8. Swine
Flu infection (H1N1)
16.8.5.4.9. COVID-19
16.8.5.4.10. Poisoning
16.8.5.4.11. Others
16.8.5.5. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
16.8.5.5.1. Online
16.8.5.5.2. Offline
16.8.5.6. Australia
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
16.8.5.6.1. Hospitals/Clinics
16.8.5.6.2. Research
Centers
16.8.5.6.3. Others
16.8.6. South
Korea
16.8.6.1. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
16.8.6.1.1. Integrated
Systems
16.8.6.1.2. Components
16.8.6.1.2.1. Oxygenators
16.8.6.1.2.2. Catheter
16.8.6.1.2.3. Heat
Exchangers
16.8.6.1.2.4. Pumps
16.8.6.1.2.5. Tubing
Kits
16.8.6.1.2.6. Back-up
Battery
16.8.6.1.2.7. Others
16.8.6.1.3. Integrated
Sensors
16.8.6.2. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
16.8.6.2.1. VA
ECMO
16.8.6.2.2. VV
ECMO
16.8.6.3. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
16.8.6.3.1. Intensive
care
16.8.6.3.2. Operation
Theatres
16.8.6.3.3. Emergency
Medicine
16.8.6.3.4. Cardiology
16.8.6.3.5. Cardiac
Surgery
16.8.6.3.6. Others
16.8.6.4. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
16.8.6.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.6.4.2. Refractory
Septic / Cardiogenic Shock
16.8.6.4.3. Myocarditis
- viral, scorpion sting
16.8.6.4.4. Post
Arrest shock
16.8.6.4.5. Meconium
Aspiration
16.8.6.4.6. Congenital
Diaphragmatic Hernia
16.8.6.4.7. Persistent
Pulmonary Hypertension
16.8.6.4.8. Swine
Flu infection (H1N1)
16.8.6.4.9. COVID-19
16.8.6.4.10. Poisoning
16.8.6.4.11. Others
16.8.6.5. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
16.8.6.5.1. Online
16.8.6.5.2. Offline
16.8.6.6. South
Korea Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
16.8.6.6.1. Hospitals/Clinics
16.8.6.6.2. Research
Centers
16.8.6.6.3. Others
16.8.7. Southeast
Asia
16.8.7.1. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Offerings
16.8.7.1.1. Integrated
Systems
16.8.7.1.2. Components
16.8.7.1.2.1. Oxygenators
16.8.7.1.2.2. Catheter
16.8.7.1.2.3. Heat
Exchangers
16.8.7.1.2.4. Pumps
16.8.7.1.2.5. Tubing
Kits
16.8.7.1.2.6. Back-up
Battery
16.8.7.1.2.7. Others
16.8.7.1.3. Integrated
Sensors
16.8.7.2. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By System Type
16.8.7.2.1. VA
ECMO
16.8.7.2.2. VV
ECMO
16.8.7.3. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Scope of Use
16.8.7.3.1. Intensive
care
16.8.7.3.2. Operation
Theatres
16.8.7.3.3. Emergency
Medicine
16.8.7.3.4. Cardiology
16.8.7.3.5. Cardiac
Surgery
16.8.7.3.6. Others
16.8.7.4. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Diseases
16.8.7.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.7.4.2. Refractory
Septic / Cardiogenic Shock
16.8.7.4.3. Myocarditis
- viral, scorpion sting
16.8.7.4.4. Post
Arrest shock
16.8.7.4.5. Meconium
Aspiration
16.8.7.4.6. Congenital
Diaphragmatic Hernia
16.8.7.4.7. Persistent
Pulmonary Hypertension
16.8.7.4.8. Swine
Flu infection (H1N1)
16.8.7.4.9. COVID-19
16.8.7.4.10. Poisoning
16.8.7.4.11. Others
16.8.7.5. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Distribution Channel
16.8.7.5.1. Online
16.8.7.5.2. Offline
16.8.7.6. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By End Users
16.8.7.6.1. Hospitals/Clinics
16.8.7.6.2. Research
Centers
16.8.7.6.3. Others
16.8.7.7. Southeast
Asia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn)
and Forecasts, By Country
16.8.7.7.1. Indonesia
16.8.7.7.2. Thailand
16.8.7.7.3. Malaysia
16.8.7.7.4. Singapore
16.8.7.7.5. Rest
of Southeast Asia
16.8.8. Rest of
Asia Pacific
16.8.8.1. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Offerings
16.8.8.1.1. Integrated
Systems
16.8.8.1.2. Components
16.8.8.1.2.1. Oxygenators
16.8.8.1.2.2. Catheter
16.8.8.1.2.3. Heat
Exchangers
16.8.8.1.2.4. Pumps
16.8.8.1.2.5. Tubing
Kits
16.8.8.1.2.6. Back-up
Battery
16.8.8.1.2.7. Others
16.8.8.1.3. Integrated
Sensors
16.8.8.2. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By System Type
16.8.8.2.1. VA
ECMO
16.8.8.2.2. VV
ECMO
16.8.8.3. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Scope of Use
16.8.8.3.1. Intensive
care
16.8.8.3.2. Operation
Theatres
16.8.8.3.3. Emergency
Medicine
16.8.8.3.4. Cardiology
16.8.8.3.5. Cardiac
Surgery
16.8.8.3.6. Others
16.8.8.4. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Diseases
16.8.8.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
16.8.8.4.2. Refractory
Septic / Cardiogenic Shock
16.8.8.4.3. Myocarditis
- viral, scorpion sting
16.8.8.4.4. Post
Arrest shock
16.8.8.4.5. Meconium
Aspiration
16.8.8.4.6. Congenital
Diaphragmatic Hernia
16.8.8.4.7. Persistent
Pulmonary Hypertension
16.8.8.4.8. Swine
Flu infection (H1N1)
16.8.8.4.9. COVID-19
16.8.8.4.10. Poisoning
16.8.8.4.11. Others
16.8.8.5. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
16.8.8.5.1. Online
16.8.8.5.2. Offline
16.8.8.6. Rest
of Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By End Users
16.8.8.6.1. Hospitals/Clinics
16.8.8.6.2. Research
Centers
16.8.8.6.3. Others
16.9. Key
Segment for Channeling Investments
16.9.1. By
Country
16.9.2. By
Offerings
16.9.3. By
System Type
16.9.4. By
Scope of Use
16.9.5. By
Diseases
16.9.6. By
Distribution Channel
16.9.7. By End
Users
17. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Analysis and Forecasts, 2020 - 2028
17.1. Overview
17.1.1. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn)
17.2. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Offerings
17.2.1. Integrated
Systems
17.2.2. Components
17.2.2.1. Oxygenators
17.2.2.2. Catheter
17.2.2.3. Heat
Exchangers
17.2.2.4. Pumps
17.2.2.5. Tubing
Kits
17.2.2.6. Back-up
Battery
17.2.2.7. Others
17.2.3. Integrated
Sensors
17.3. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By System Type
17.3.1. VA ECMO
17.3.2. VV ECMO
17.4. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Scope of Use
17.4.1. Intensive
care
17.4.2. Operation
Theatres
17.4.3. Emergency
Medicine
17.4.4. Cardiology
17.4.5. Cardiac
Surgery
17.4.6. Others
17.5. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Diseases
17.5.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.5.2. Refractory
Septic / Cardiogenic Shock
17.5.3. Myocarditis
- viral, scorpion sting
17.5.4. Post
Arrest shock
17.5.5. Meconium
Aspiration
17.5.6. Congenital
Diaphragmatic Hernia
17.5.7. Persistent
Pulmonary Hypertension
17.5.8. Swine
Flu infection (H1N1)
17.5.9. COVID-19
17.5.10. Poisoning
17.5.11. Others
17.6. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.6.1. Online
17.6.2. Offline
17.7. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By End Users
17.7.1. Hospitals/Clinics
17.7.2. Research
Centers
17.7.3. Others
17.8. Middle
East and Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Country
17.8.1. Saudi
Arabia
17.8.1.1. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
17.8.1.1.1. Integrated
Systems
17.8.1.1.2. Components
17.8.1.1.2.1. Oxygenators
17.8.1.1.2.2. Catheter
17.8.1.1.2.3. Heat
Exchangers
17.8.1.1.2.4. Pumps
17.8.1.1.2.5. Tubing
Kits
17.8.1.1.2.6. Back-up
Battery
17.8.1.1.2.7. Others
17.8.1.1.3. Integrated
Sensors
17.8.1.2. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
17.8.1.2.1. VA
ECMO
17.8.1.2.2. VV
ECMO
17.8.1.3. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
17.8.1.3.1. Intensive
care
17.8.1.3.2. Operation
Theatres
17.8.1.3.3. Emergency
Medicine
17.8.1.3.4. Cardiology
17.8.1.3.5. Cardiac
Surgery
17.8.1.3.6. Others
17.8.1.4. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
17.8.1.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.1.4.2. Refractory
Septic / Cardiogenic Shock
17.8.1.4.3. Myocarditis
- viral, scorpion sting
17.8.1.4.4. Post
Arrest shock
17.8.1.4.5. Meconium
Aspiration
17.8.1.4.6. Congenital
Diaphragmatic Hernia
17.8.1.4.7. Persistent
Pulmonary Hypertension
17.8.1.4.8. Swine
Flu infection (H1N1)
17.8.1.4.9. COVID-19
17.8.1.4.10. Poisoning
17.8.1.4.11. Others
17.8.1.5. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
17.8.1.5.1. Online
17.8.1.5.2. Offline
17.8.1.6. Saudi
Arabia Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
17.8.1.6.1. Hospitals/Clinics
17.8.1.6.2. Research
Centers
17.8.1.6.3. Others
17.8.2. UAE
17.8.2.1. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
17.8.2.1.1. Integrated
Systems
17.8.2.1.2. Components
17.8.2.1.2.1. Oxygenators
17.8.2.1.2.2. Catheter
17.8.2.1.2.3. Heat
Exchangers
17.8.2.1.2.4. Pumps
17.8.2.1.2.5. Tubing
Kits
17.8.2.1.2.6. Back-up
Battery
17.8.2.1.2.7. Others
17.8.2.1.3. Integrated
Sensors
17.8.2.2. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
17.8.2.2.1. VA
ECMO
17.8.2.2.2. VV
ECMO
17.8.2.3. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
17.8.2.3.1. Intensive
care
17.8.2.3.2. Operation
Theatres
17.8.2.3.3. Emergency
Medicine
17.8.2.3.4. Cardiology
17.8.2.3.5. Cardiac
Surgery
17.8.2.3.6. Others
17.8.2.4. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
17.8.2.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.2.4.2. Refractory
Septic / Cardiogenic Shock
17.8.2.4.3. Myocarditis
- viral, scorpion sting
17.8.2.4.4. Post
Arrest shock
17.8.2.4.5. Meconium
Aspiration
17.8.2.4.6. Congenital
Diaphragmatic Hernia
17.8.2.4.7. Persistent
Pulmonary Hypertension
17.8.2.4.8. Swine
Flu infection (H1N1)
17.8.2.4.9. COVID-19
17.8.2.4.10. Poisoning
17.8.2.4.11. Others
17.8.2.5. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.8.2.5.1. Online
17.8.2.5.2. Offline
17.8.2.6. UAE
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
17.8.2.6.1. Hospitals/Clinics
17.8.2.6.2. Research
Centers
17.8.2.6.3. Others
17.8.3. Egypt
17.8.3.1. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
17.8.3.1.1. Integrated
Systems
17.8.3.1.2. Components
17.8.3.1.2.1. Oxygenators
17.8.3.1.2.2. Catheter
17.8.3.1.2.3. Heat
Exchangers
17.8.3.1.2.4. Pumps
17.8.3.1.2.5. Tubing
Kits
17.8.3.1.2.6. Back-up
Battery
17.8.3.1.2.7. Others
17.8.3.1.3. Integrated
Sensors
17.8.3.2. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
17.8.3.2.1. VA
ECMO
17.8.3.2.2. VV
ECMO
17.8.3.3. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
17.8.3.3.1. Intensive
care
17.8.3.3.2. Operation
Theatres
17.8.3.3.3. Emergency
Medicine
17.8.3.3.4. Cardiology
17.8.3.3.5. Cardiac
Surgery
17.8.3.3.6. Others
17.8.3.4. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
17.8.3.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.3.4.2. Refractory
Septic / Cardiogenic Shock
17.8.3.4.3. Myocarditis
- viral, scorpion sting
17.8.3.4.4. Post
Arrest shock
17.8.3.4.5. Meconium
Aspiration
17.8.3.4.6. Congenital
Diaphragmatic Hernia
17.8.3.4.7. Persistent
Pulmonary Hypertension
17.8.3.4.8. Swine
Flu infection (H1N1)
17.8.3.4.9. COVID-19
17.8.3.4.10. Poisoning
17.8.3.4.11. Others
17.8.3.5. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.8.3.5.1. Online
17.8.3.5.2. Offline
17.8.3.6. Egypt
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
17.8.3.6.1. Hospitals/Clinics
17.8.3.6.2. Research
Centers
17.8.3.6.3. Others
17.8.4. Kuwait
17.8.4.1. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
17.8.4.1.1. Integrated
Systems
17.8.4.1.2. Components
17.8.4.1.2.1. Oxygenators
17.8.4.1.2.2. Catheter
17.8.4.1.2.3. Heat
Exchangers
17.8.4.1.2.4. Pumps
17.8.4.1.2.5. Tubing
Kits
17.8.4.1.2.6. Back-up
Battery
17.8.4.1.2.7. Others
17.8.4.1.3. Integrated
Sensors
17.8.4.2. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
17.8.4.2.1. VA
ECMO
17.8.4.2.2. VV
ECMO
17.8.4.3. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
17.8.4.3.1. Intensive
care
17.8.4.3.2. Operation
Theatres
17.8.4.3.3. Emergency
Medicine
17.8.4.3.4. Cardiology
17.8.4.3.5. Cardiac
Surgery
17.8.4.3.6. Others
17.8.4.4. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
17.8.4.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.4.4.2. Refractory
Septic / Cardiogenic Shock
17.8.4.4.3. Myocarditis
- viral, scorpion sting
17.8.4.4.4. Post
Arrest shock
17.8.4.4.5. Meconium
Aspiration
17.8.4.4.6. Congenital
Diaphragmatic Hernia
17.8.4.4.7. Persistent
Pulmonary Hypertension
17.8.4.4.8. Swine
Flu infection (H1N1)
17.8.4.4.9. COVID-19
17.8.4.4.10. Poisoning
17.8.4.4.11. Others
17.8.4.5. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
17.8.4.5.1. Online
17.8.4.5.2. Offline
17.8.4.6. Kuwait
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
17.8.4.6.1. Hospitals/Clinics
17.8.4.6.2. Research
Centers
17.8.4.6.3. Others
17.8.5. South
Africa
17.8.5.1. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
17.8.5.1.1. Integrated
Systems
17.8.5.1.2. Components
17.8.5.1.2.1. Oxygenators
17.8.5.1.2.2. Catheter
17.8.5.1.2.3. Heat
Exchangers
17.8.5.1.2.4. Pumps
17.8.5.1.2.5. Tubing
Kits
17.8.5.1.2.6. Back-up
Battery
17.8.5.1.2.7. Others
17.8.5.1.3. Integrated
Sensors
17.8.5.2. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
17.8.5.2.1. VA
ECMO
17.8.5.2.2. VV
ECMO
17.8.5.3. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
17.8.5.3.1. Intensive
care
17.8.5.3.2. Operation
Theatres
17.8.5.3.3. Emergency
Medicine
17.8.5.3.4. Cardiology
17.8.5.3.5. Cardiac
Surgery
17.8.5.3.6. Others
17.8.5.4. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
17.8.5.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.5.4.2. Refractory
Septic / Cardiogenic Shock
17.8.5.4.3. Myocarditis
- viral, scorpion sting
17.8.5.4.4. Post
Arrest shock
17.8.5.4.5. Meconium
Aspiration
17.8.5.4.6. Congenital
Diaphragmatic Hernia
17.8.5.4.7. Persistent
Pulmonary Hypertension
17.8.5.4.8. Swine
Flu infection (H1N1)
17.8.5.4.9. COVID-19
17.8.5.4.10. Poisoning
17.8.5.4.11. Others
17.8.5.5. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
17.8.5.5.1. Online
17.8.5.5.2. Offline
17.8.5.6. South
Africa Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
17.8.5.6.1. Hospitals/Clinics
17.8.5.6.2. Research
Centers
17.8.5.6.3. Others
17.8.6. Rest of
Middle East & Africa
17.8.6.1. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By Offerings
17.8.6.1.1. Integrated
Systems
17.8.6.1.2. Components
17.8.6.1.2.1. Oxygenators
17.8.6.1.2.2. Catheter
17.8.6.1.2.3. Heat
Exchangers
17.8.6.1.2.4. Pumps
17.8.6.1.2.5. Tubing
Kits
17.8.6.1.2.6. Back-up
Battery
17.8.6.1.2.7. Others
17.8.6.1.3. Integrated
Sensors
17.8.6.2. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By System Type
17.8.6.2.1. VA
ECMO
17.8.6.2.2. VV
ECMO
17.8.6.3. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By Scope of Use
17.8.6.3.1. Intensive
care
17.8.6.3.2. Operation
Theatres
17.8.6.3.3. Emergency
Medicine
17.8.6.3.4. Cardiology
17.8.6.3.5. Cardiac
Surgery
17.8.6.3.6. Others
17.8.6.4. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By Diseases
17.8.6.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
17.8.6.4.2. Refractory
Septic / Cardiogenic Shock
17.8.6.4.3. Myocarditis
- viral, scorpion sting
17.8.6.4.4. Post
Arrest shock
17.8.6.4.5. Meconium
Aspiration
17.8.6.4.6. Congenital
Diaphragmatic Hernia
17.8.6.4.7. Persistent
Pulmonary Hypertension
17.8.6.4.8. Swine
Flu infection (H1N1)
17.8.6.4.9. COVID-19
17.8.6.4.10. Poisoning
17.8.6.4.11. Others
17.8.6.5. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By Distribution Channel
17.8.6.5.1. Online
17.8.6.5.2. Offline
17.8.6.6. Rest
of Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Devices
Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.6.6.1. Hospitals/Clinics
17.8.6.6.2. Research
Centers
17.8.6.6.3. Others
17.9. Key
Segment for Channeling Investments
17.9.1. By
Country
17.9.2. By
Offerings
17.9.3. By
System Type
17.9.4. By
Scope of Use
17.9.5. By
Diseases
17.9.6. By
Distribution Channel
17.9.7. By End
Users
18. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Analysis and
Forecasts, 2020 - 2028
18.1. Overview
18.1.1. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn)
18.2. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Offerings
18.2.1. Integrated
Systems
18.2.2. Components
18.2.2.1. Oxygenators
18.2.2.2. Catheter
18.2.2.3. Heat
Exchangers
18.2.2.4. Pumps
18.2.2.5. Tubing
Kits
18.2.2.6. Back-up
Battery
18.2.2.7. Others
18.2.3. Integrated
Sensors
18.3. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By System Type
18.3.1. VA ECMO
18.3.2. VV ECMO
18.4. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Scope of Use
18.4.1. Intensive
care
18.4.2. Operation
Theatres
18.4.3. Emergency
Medicine
18.4.4. Cardiology
18.4.5. Cardiac
Surgery
18.4.6. Others
18.5. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Diseases
18.5.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
18.5.2. Refractory
Septic / Cardiogenic Shock
18.5.3. Myocarditis
- viral, scorpion sting
18.5.4. Post
Arrest shock
18.5.5. Meconium
Aspiration
18.5.6. Congenital
Diaphragmatic Hernia
18.5.7. Persistent
Pulmonary Hypertension
18.5.8. Swine
Flu infection (H1N1)
18.5.9. COVID-19
18.5.10. Poisoning
18.5.11. Others
18.6. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Distribution Channel
18.6.1. Online
18.6.2. Offline
18.7. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By End Users
18.7.1. Hospitals/Clinics
18.7.2. Research
Centers
18.7.3. Others
18.8. Latin
America Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$
Mn) and Forecasts, By Country
18.8.1. Brazil
18.8.1.1. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
18.8.1.1.1. Integrated
Systems
18.8.1.1.2. Components
18.8.1.1.2.1. Oxygenators
18.8.1.1.2.2. Catheter
18.8.1.1.2.3. Heat
Exchangers
18.8.1.1.2.4. Pumps
18.8.1.1.2.5. Tubing
Kits
18.8.1.1.2.6. Back-up
Battery
18.8.1.1.2.7. Others
18.8.1.1.3. Integrated
Sensors
18.8.1.2. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
18.8.1.2.1. VA
ECMO
18.8.1.2.2. VV
ECMO
18.8.1.3. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
18.8.1.3.1. Intensive
care
18.8.1.3.2. Operation
Theatres
18.8.1.3.3. Emergency
Medicine
18.8.1.3.4. Cardiology
18.8.1.3.5. Cardiac
Surgery
18.8.1.3.6. Others
18.8.1.4. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
18.8.1.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
18.8.1.4.2. Refractory
Septic / Cardiogenic Shock
18.8.1.4.3. Myocarditis
- viral, scorpion sting
18.8.1.4.4. Post
Arrest shock
18.8.1.4.5. Meconium
Aspiration
18.8.1.4.6. Congenital
Diaphragmatic Hernia
18.8.1.4.7. Persistent
Pulmonary Hypertension
18.8.1.4.8. Swine
Flu infection (H1N1)
18.8.1.4.9. COVID-19
18.8.1.4.10. Poisoning
18.8.1.4.11. Others
18.8.1.5. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
18.8.1.5.1. Online
18.8.1.5.2. Offline
18.8.1.6. Brazil
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
18.8.1.6.1. Hospitals/Clinics
18.8.1.6.2. Research
Centers
18.8.1.6.3. Others
18.8.2. Argentina
18.8.2.1. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Offerings
18.8.2.1.1. Integrated
Systems
18.8.2.1.2. Components
18.8.2.1.2.1. Oxygenators
18.8.2.1.2.2. Catheter
18.8.2.1.2.3. Heat
Exchangers
18.8.2.1.2.4. Pumps
18.8.2.1.2.5. Tubing
Kits
18.8.2.1.2.6. Back-up
Battery
18.8.2.1.2.7. Others
18.8.2.1.3. Integrated
Sensors
18.8.2.2. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By System Type
18.8.2.2.1. VA
ECMO
18.8.2.2.2. VV
ECMO
18.8.2.3. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Scope of Use
18.8.2.3.1. Intensive
care
18.8.2.3.2. Operation
Theatres
18.8.2.3.3. Emergency
Medicine
18.8.2.3.4. Cardiology
18.8.2.3.5. Cardiac
Surgery
18.8.2.3.6. Others
18.8.2.4. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Diseases
18.8.2.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
18.8.2.4.2. Refractory
Septic / Cardiogenic Shock
18.8.2.4.3. Myocarditis
- viral, scorpion sting
18.8.2.4.4. Post
Arrest shock
18.8.2.4.5. Meconium
Aspiration
18.8.2.4.6. Congenital
Diaphragmatic Hernia
18.8.2.4.7. Persistent
Pulmonary Hypertension
18.8.2.4.8. Swine
Flu infection (H1N1)
18.8.2.4.9. COVID-19
18.8.2.4.10. Poisoning
18.8.2.4.11. Others
18.8.2.5. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By Distribution Channel
18.8.2.5.1. Online
18.8.2.5.2. Offline
18.8.2.6. Argentina
Extracorporeal Membrane Oxygenation (ECMO) Devices Market Revenue (US$ Mn) and
Forecasts, By End Users
18.8.2.6.1. Hospitals/Clinics
18.8.2.6.2. Research
Centers
18.8.2.6.3. Others
18.8.3. Rest of
Latin America
18.8.3.1. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Offerings
18.8.3.1.1. Integrated
Systems
18.8.3.1.2. Components
18.8.3.1.2.1. Oxygenators
18.8.3.1.2.2. Catheter
18.8.3.1.2.3. Heat
Exchangers
18.8.3.1.2.4. Pumps
18.8.3.1.2.5. Tubing
Kits
18.8.3.1.2.6. Back-up
Battery
18.8.3.1.2.7. Others
18.8.3.1.3. Integrated
Sensors
18.8.3.2. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By System Type
18.8.3.2.1. VA
ECMO
18.8.3.2.2. VV
ECMO
18.8.3.3. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Scope of Use
18.8.3.3.1. Intensive
care
18.8.3.3.2. Operation
Theatres
18.8.3.3.3. Emergency
Medicine
18.8.3.3.4. Cardiology
18.8.3.3.5. Cardiac
Surgery
18.8.3.3.6. Others
18.8.3.4. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Diseases
18.8.3.4.1. Acute
Respiratory Distress Syndrome (ARDS) secondary to pneumonia, aspiration, severe
air leak
18.8.3.4.2. Refractory
Septic / Cardiogenic Shock
18.8.3.4.3. Myocarditis
- viral, scorpion sting
18.8.3.4.4. Post
Arrest shock
18.8.3.4.5. Meconium
Aspiration
18.8.3.4.6. Congenital
Diaphragmatic Hernia
18.8.3.4.7. Persistent
Pulmonary Hypertension
18.8.3.4.8. Swine
Flu infection (H1N1)
18.8.3.4.9. COVID-19
18.8.3.4.10. Poisoning
18.8.3.4.11. Others
18.8.3.5. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By Distribution Channel
18.8.3.5.1. Online
18.8.3.5.2. Offline
18.8.3.6. Rest
of Latin America Extracorporeal Membrane Oxygenation (ECMO) Devices Market
Revenue (US$ Mn) and Forecasts, By End Users
18.8.3.6.1. Hospitals/Clinics
18.8.3.6.2. Research
Centers
18.8.3.6.3. Others
18.9. Key
Segment for Channeling Investments
18.9.1. By
Country
18.9.2. By
Offerings
18.9.3. By
System Type
18.9.4. By
Scope of Use
18.9.5. By
Diseases
18.9.6. By
Distribution Channel
18.9.7. By End
Users
19. Competitive
Benchmarking
19.1. Market
Share Analysis, 2019
19.2. Global
Presence and Growth Strategies
19.2.1. Mergers
and Acquisitions
19.2.2. Product
Launches
19.2.3. Investments
Trends
19.2.4. R&D
Initiatives
20. Player
Profiles
20.1. ALung
Technologies, Inc.
20.1.1. Company
Details
20.1.2. Company
Overview
20.1.3. Product
Offerings
20.1.4. Key
Developments
20.1.5. Financial
Analysis
20.1.6. SWOT
Analysis
20.1.7. Business
Strategies
20.2. CORMED
Medizintechnik GmbH & Co. KG
20.2.1. Company
Details
20.2.2. Company
Overview
20.2.3. Product
Offerings
20.2.4. Key
Developments
20.2.5. Financial
Analysis
20.2.6. SWOT
Analysis
20.2.7. Business
Strategies
20.3. CytoSorbents
Europe GmbH
20.3.1. Company
Details
20.3.2. Company
Overview
20.3.3. Product
Offerings
20.3.4. Key
Developments
20.3.5. Financial
Analysis
20.3.6. SWOT
Analysis
20.3.7. Business
Strategies
20.4. EUROSETS
20.4.1. Company
Details
20.4.2. Company
Overview
20.4.3. Product
Offerings
20.4.4. Key
Developments
20.4.5. Financial
Analysis
20.4.6. SWOT
Analysis
20.4.7. Business
Strategies
20.5. Fresenius
Medical Care
20.5.1. Company
Details
20.5.2. Company
Overview
20.5.3. Product
Offerings
20.5.4. Key Developments
20.5.5. Financial
Analysis
20.5.6. SWOT
Analysis
20.5.7. Business
Strategies
20.6. Getinge
AB
20.6.1. Company
Details
20.6.2. Company
Overview
20.6.3. Product
Offerings
20.6.4. Key
Developments
20.6.5. Financial
Analysis
20.6.6. SWOT
Analysis
20.6.7. Business
Strategies
20.7. LivaNova
PLC (CardiacAssist, Inc)
20.7.1. Company
Details
20.7.2. Company
Overview
20.7.3. Product
Offerings
20.7.4. Key
Developments
20.7.5. Financial
Analysis
20.7.6. SWOT
Analysis
20.7.7. Business
Strategies
20.8. MC3
Cardiopulmonary
20.8.1. Company
Details
20.8.2. Company
Overview
20.8.3. Product
Offerings
20.8.4. Key
Developments
20.8.5. Financial
Analysis
20.8.6. SWOT
Analysis
20.8.7. Business
Strategies
20.9. Medtronic
20.9.1. Company
Details
20.9.2. Company
Overview
20.9.3. Product
Offerings
20.9.4. Key
Developments
20.9.5. Financial
Analysis
20.9.6. SWOT
Analysis
20.9.7. Business
Strategies
20.10. MicroPort
Scientific Corporation
20.10.1. Company
Details
20.10.2. Company
Overview
20.10.3. Product
Offerings
20.10.4. Key
Developments
20.10.5. Financial
Analysis
20.10.6. SWOT
Analysis
20.10.7. Business
Strategies
20.11. NIPRO
20.11.1. Company
Details
20.11.2. Company
Overview
20.11.3. Product
Offerings
20.11.4. Key
Developments
20.11.5. Financial
Analysis
20.11.6. SWOT
Analysis
20.11.7. Business
Strategies
20.12. Terumo
Cardiovascular Systems Corporation
20.12.1. Company
Details
20.12.2. Company
Overview
20.12.3. Product
Offerings
20.12.4. Key
Developments
20.12.5. Financial
Analysis
20.12.6. SWOT
Analysis
20.12.7. Business Strategies
20.13. Other
Industry Participants
21. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise
User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.